Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Disregard the previous ifu for product pm 100 (wb) whole blood toxicology control. the previous ifu claimed a higher reference value for the analyte methadone primary metabolite (eddp). there is an indication at the bottom of the method table in the new ifu outlining that there is no claim made for expected values or stability.